112 related articles for article (PubMed ID: 17244362)
21. Methotrexate in atherogenesis and cholesterol metabolism.
Coomes E; Chan ES; Reiss AB
Cholesterol; 2011; 2011():503028. PubMed ID: 21490773
[TBL] [Abstract][Full Text] [Related]
22. COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.
Anwar K; Voloshyna I; Littlefield MJ; Carsons SE; Wirkowski PA; Jaber NL; Sohn A; Eapen S; Reiss AB
Lipids; 2011 Feb; 46(2):131-42. PubMed ID: 21181286
[TBL] [Abstract][Full Text] [Related]
23. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.
Yin K; Liao DF; Tang CK
Mol Med; 2010; 16(9-10):438-49. PubMed ID: 20485864
[TBL] [Abstract][Full Text] [Related]
24. A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux.
Bingham TC; Fisher EA; Parathath S; Reiss AB; Chan ES; Cronstein BN
J Leukoc Biol; 2010 Apr; 87(4):683-90. PubMed ID: 20089670
[TBL] [Abstract][Full Text] [Related]
25. Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
Reiss AB; Anwar K; Merrill JT; Chan ES; Awadallah NW; Cronstein BN; Michael Belmont H; Belilos E; Rosenblum G; Belostocki K; Bonetti L; Hasneen K; Carsons SE
Rheumatol Int; 2010 Mar; 30(5):591-8. PubMed ID: 19547978
[TBL] [Abstract][Full Text] [Related]
26. A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.
Narasimha A; Watanabe J; Lin JA; Hama S; Langenbach R; Navab M; Fogelman AM; Reddy ST
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):24-33. PubMed ID: 17643885
[TBL] [Abstract][Full Text] [Related]
27. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
28. [Role of the ABC transporters A1 and G1, key reverse cholesterol transport proteins, in atherosclerosis].
Demina EP; Miroshnikova VV; Schwarzman AL
Mol Biol (Mosk); 2016; 50(2):223-30. PubMed ID: 27239842
[TBL] [Abstract][Full Text] [Related]
29. Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.
Chan ES; Zhang H; Fernandez P; Edelman SD; Pillinger MH; Ragolia L; Palaia T; Carsons S; Reiss AB
Arthritis Res Ther; 2007; 9(1):R4. PubMed ID: 17244362
[TBL] [Abstract][Full Text] [Related]
30. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages.
Reiss AB; Carsons SE; Anwar K; Rao S; Edelman SD; Zhang H; Fernandez P; Cronstein BN; Chan ES
Arthritis Rheum; 2008 Dec; 58(12):3675-83. PubMed ID: 19035488
[TBL] [Abstract][Full Text] [Related]
31. COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
Voloshyna I; Kasselman LJ; Carsons SE; Littlefield MJ; Gomolin IH; De Leon J; Reiss AB
J Investig Med; 2017 Mar; 65(3):694-704. PubMed ID: 27940550
[TBL] [Abstract][Full Text] [Related]
32. Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells.
Tang CK; Tang GH; Yi GH; Wang Z; Liu LS; Wan S; Yuan ZH; He XS; Yang JH; Ruan CG; Yang YZ
Acta Biochim Biophys Sin (Shanghai); 2004 Mar; 36(3):218-26. PubMed ID: 15202507
[TBL] [Abstract][Full Text] [Related]
33. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages.
Reiss AB; Rahman MM; Chan ES; Montesinos MC; Awadallah NW; Cronstein BN
J Leukoc Biol; 2004 Sep; 76(3):727-34. PubMed ID: 15197231
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Qiu G; Hill JS
J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
McGettigan P; Henry D
JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
